Ethical concerns regarding heterologous COVID-19 vaccine administration
Saved in:
Main Authors: | Somsri Wiwanitkit (Author), Viroj Wiwanitkit (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heterologous COVID-19 vaccination in pregnant women: Comment
by: Pathum Sookaromdee, et al.
Published: (2023) -
Willingness of college students to receive COVID-19 heterologous vaccination: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023) -
Hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
by: Somsri Wiwanitkit, et al.
Published: (2023) -
Politics and confidence toward the COVID-19 vaccination: Points to be considered
by: Somsri Wiwanitkit, et al.
Published: (2024) -
Heterologous mRNA-based COVID-19 booster strategies: Comment
by: Sora Yasri, et al.
Published: (2023)